Skip to main content
. 2004 Jan 26;2004(1):CD003545. doi: 10.1002/14651858.CD003545.pub2

O'Brien 1974.

Methods Allocation: randomly assigned (code held by a technician who was not responsible for allocation). 
 Blindness: double (identical capsules, coded bottles). 
 Design: 2 parallel groups, 2 centres. 
 Duration: 3 weeks. 
 Analysis: intention‐to‐treat not performed in the trial. 
 Country: USA.
Participants Diagnosis: patients with symptoms of hostility, suspiciousness, paranoia and aggressiveness; 20 schizophrenics*. 
 N=30. 
 Age: mean ˜30 years. 
 Sex: M 22, F 2. 
 Setting: hospital.
Interventions 1. Trifluoperazine: dose 9‐48 mg/day. N=15. 
 2. Haloperidol: dose 3‐20 mg/day. N=15.
Outcomes Global state. 
 Leaving the study early. 
 Use of antiparkinson agents.
Unable to use ‐ 
 Mental state: (BPRS; Global Hostility; Global Paranoia ‐ no SD). 
 Psychological Tests: (Buss‐Durkee hostility inventory; Rozenzweig picture frustration test; MMPI and Rorshach test ‐ no data).
Notes **Mixed diagnosis.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate